Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes

Inclusion Criteria: * Male and female patients over the age of 18 years. * Patients scheduled for clinically indicated coronary angiography and possible ad hoc percutaneous coronary intervention (PCI) will be evaluated before their scheduled procedure. * Written informed consent (approved by the Institutional Review Board \[IRB\]/Independent Ethics Committee \[IEC\]) obtained prior to any study specific procedures. * Patients considered to be stable at enrollment (at the discretion of the investigator) are eligible provided they meet all other entry criteria. * Angiogram meeting qualifying criteria Exclusion Criteria: * Women of childbearing potential (women who are not surgically sterile or postmenopausal defined as amenorrhea for \>12 months) who refuse to undergo a urine or serum pregnancy test immediately prior to baseline and repeat imaging evaluations The urine or serum pregnancy test must be negative prior to imaging evaluations. * Previous coronary artery bypass graft (CABG) surgery or probable need for CABG in the next 24 months. * Patients who have symptomatic congestive heart failure (CHF) (New York Heart Association \[NYHA\] Class III or IV) at baseline. * Patients with clinically significant valvular heart disease likely to require surgical repair or replacement during the treatment period of the study * Any clinically significant medical condition or presence of any laboratory abnormality that is considered by the investigator to be clinically important and could interfere with the conduct of the study. * The presence of severe liver disease as defined by the presence of cirrhosis, chronic active hepatitis, or chronic jaundice with hyperbilirubinemia, * Patients with eGFR \< 45 ml/min prior to baseline imaging procedures, or with nephrotic syndrome * Patients with a life expectancy less than 2 years. * History of malignancy (except for curatively treated basal cell or squamous cell carcinoma of the skin) during the 3 years prior to the screening. * Unable or unwilling to comply with protocol requirements, or deemed by the investigator to be unfit for the study.